- Report
- August 2024
Global
From €9031EUR$9,500USD£7,587GBP
- Report
- August 2024
Europe
From €7130EUR$7,500USD£5,990GBP
- Report
- October 2021
- 350 Pages
Global
From €7130EUR$7,500USD£5,990GBP
- Report
- July 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- July 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- December 2021
- 159 Pages
Global
From €3529EUR$3,712USD£2,965GBP
- Book
- February 2024
North America
The Sexually Transmitted Disease (STD) Test market is a subset of the Diagnostics industry. STD tests are used to detect the presence of a sexually transmitted infection, such as chlamydia, gonorrhea, syphilis, and HIV. These tests are typically conducted in a laboratory setting, and may involve a physical examination, a blood test, or a urine test. The results of these tests can help diagnose and treat an infection, as well as prevent the spread of the disease.
The STD Test market is driven by the increasing prevalence of STDs, as well as the need for early detection and treatment. Additionally, the availability of rapid testing technologies has made STD testing more accessible and affordable.
Some companies in the STD Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more